Showing results 1 to 60 of 70
|A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
|Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
|Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor γ, controls hepatitis B virus replication
|김경민, 박선, 신호준, 윤사라, 최용준
|An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases
|PIRACHA, ZAHRA ZAHID, 김경민, 박선, 신호준, 최용준
|Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus
|김기범, 김순선, 정재연, 조성원, 조진희
|Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
|김진홍, 정재연, 조성원, 함기백
|Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication
|Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection.
|Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
|Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients
|C-terminal substitution of HBV core proteins with those from DHBV reveals that arginine-rich 167RRRSQSPRR175 domain is critical for HBV replication
|김경민, 박선, 신호준, 최용준
|Ca2+/Calmodulin-Dependent Protein Kinase II Inhibits Hepatitis B Virus Replication from cccDNA via AMPK Activation and AKT/mTOR Suppression
|김경민, 박선, 신호준, 최용준
|Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy
|김순선, 김진홍, 유병무, 이광재, 이기명, 이명희, 정재연, 조성원
|Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.
|Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.
|김순선, 이명희, 정재연, 조성원
|Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis
|Differential Expression of HBx Protein in the Liver from Patients with Chronic hepatitis, Cirrhosis and Hepatocellular Carcinoma
|이재호, 조혜성, 진윤미
|Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
|Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells.
|김경민, 박선, 신호준
|Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion.
|김진홍, 이기명, 조성원, 함기백
|Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis B.
|Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis
|Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study
|Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B
|김순선, 임영애, 정재연, 조성원
|Evaluation of the VITROS 3600 Analyzer for HBsAg
|Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA.
|Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
|Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma.
|Functional Role of Hepatitis B Virus Core Protein in Viral Replication
|Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma
|김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정
|Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
|Hepatitis B Virus Infection: Fatigue-Associated Illness Experiences Among Koreans
|Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression.
|김영배, 박용예, 이영수, 조혜성, 지재훈
|Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection.
|Hepatitis B virus X protein induced expression of the Nur77 gene.
|Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners.
|김경민, 김수정, 손성향, 조혜성
|High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation.
|김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정
|HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo.
|Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population
|Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
|Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.
|김경민, 박선, 신호준, 정재성
|Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma
|김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정
|Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
|강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정
|Intracellular antibody fragment against hepatitis B virus X protein does not inhibit viral replication.
|김경민, 박선, 신호준, 홍승호
|Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population.
|김진홍, 정재연, 조성원, 함기백
|Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.
|고경현, 이명희, 정재연, 조성원
|Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
|김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정
|Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis
|NGUYEN, THI KIM OANH, 이호수, 조미영, 조혜성
|Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
|김순선, 정재연, 조성원
|Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle.
|김경민, 박선, 신호준
|Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner
|김경민, 박선, 신호준, 최용준
|Peptidyl-prolyl cis/trans isomerase Pin1 interacts with hepatitis B virus core particle, but not with HBc protein, to promote HBV replication
|김경민, 김주미, 박선, 신호준
|Phosphoacceptors threonine 162 and serines 170 and 178 within the carboxyl-terminal RRRS/T motif of the hepatitis B virus core protein make multiple contributions to hepatitis B virus replication.
|김경민, 박선, 신호준, 정재성, 최용준
|Pin1 Interacts with Hepatitis B Virus Core Particle and Enhances HBV Replication
|Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
|PPIases Par14/Par17 Affect HBV Replication in Multiple Ways
|Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells.
|RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
|김진홍, 정재연, 조성원
|Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
|Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study